Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Ton J Rabelink
Introduction
Ton J Rabelink is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of cardiovascular and neurological disorders. His innovative approach focuses on modulating the activity of nitric oxide synthase, which plays a crucial role in various physiological processes.
Latest Patents
Rabelink holds a patent for a pharmaceutical preparation aimed at treating or preventing cardiovascular or neurological disorders by modulating the activity of nitric oxide synthase. This invention utilizes folic acid or a folate in combination with tetrahydrobiopterin (BH4) or its derivatives. The patent emphasizes the importance of influencing nitric oxide (NO) levels without negatively impacting other risk factors such as lipids, blood pressure, and homocysteine. The clinical applications of this invention are vast, addressing anomalies in nitric oxide levels and providing potential solutions for cardiovascular and neurological conditions.
Career Highlights
Ton J Rabelink is associated with Eprov AG, where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to addressing complex health issues through pharmaceutical preparations. Rabelink's dedication to improving patient outcomes through scientific research is evident in his patent and ongoing projects.
Collaborations
Rabelink collaborates with Rudolf Moser, contributing to the advancement of their shared goals in the pharmaceutical industry. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in medical science.
Conclusion
Ton J Rabelink's contributions to the field of pharmaceuticals highlight the potential for innovation in treating complex health disorders. His patent reflects a commitment to improving health outcomes through scientific research and collaboration.